BESPONSA vs IDAMYCIN PFS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. BESPONSA and IDAMYCIN PFS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BESPONSA	IDAMYCIN PFS
Rating	New	64/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	INOTUZUMAB OZOGAMICIN	IDARUBICIN HYDROCHLORIDE
Manufacturer	Wyeth Pharms Inc	Pfizer
Dosage forms	Injectable	Solution
Drug class	Cd22-Directed Immunoconjugate	Anthracycline Topoisomerase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia

besponsa idamycin pfs

Rating

New

64/100

Pharmacy pays

—

Type

Active ingredient

INOTUZUMAB OZOGAMICIN

IDARUBICIN HYDROCHLORIDE

Manufacturer

Wyeth Pharms Inc

Pfizer

Dosage forms

Injectable

Solution

Drug class

Cd22-Directed Immunoconjugate

Anthracycline Topoisomerase Inhibitor

Boxed warning

Treats

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia

Frequently asked questions

What is the difference between Besponsa and Idamycin Pfs?

Besponsa contains Inotuzumab Ozogamicin, while Idamycin Pfs contains Idarubicin Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.